Treatment of steroid-induced elevated intraocular pressure with anecortave acetate: A randomized clinical trial

Journal of Ocular Pharmacology and Therapeutics

Volumn 28, Issue 6, 2012, Pages 559-565

  Stalmans, Ingeborg ^a   Callanan, David G ^b,c   Dirks, Monte S ^d   Moster, Marlene R ^e,f   Robin, Alan L ^g,h   Van Calster, Joachim ^a   Scheib, Sally A ⁱ   Dickerson, Jaime E ^j,k   Landry, Theresa A ⁱ   Bergamini, Michael V W ^j  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c TEXAS RETINA ASSOCIATES   (United States)

^d Black Hills Regional Eye Institute   (United States)

^e WILLS EYE HOSPITAL   (United States)

^f Ophthalmic Partners of Pennsylvania   (United States)

^g UNIVERSITY OF MARYLAND   (United States)

^h JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ ALCON RESEARCH LTD   (United States)

^j UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^k Medical and Clinical Affairs   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANECORTAVE; CORTICOSTEROID; PLACEBO;

ADULT; ARTICLE; BLURRED VISION; CATARACT; CONJUNCTIVAL HEMORRHAGE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; EYE DISCOMFORT; EYE FUNDUS; EYE MOVEMENT; EYE PAIN; FEMALE; HUMAN; HYPEREMIA; INTRAOCULAR HYPERTENSION; IRITIS; KERATITIS; MAJOR CLINICAL STUDY; MALE; PRESSURE MEASUREMENT; RANDOMIZED CONTROLLED TRIAL; SLIT LAMP; TREATMENT FAILURE; VISUAL ACUITY;

ADULT; AGED; ANTERIOR EYE SEGMENT; ANTIHYPERTENSIVE AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG DELIVERY SYSTEMS; GLUCOCORTICOIDS; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; PREGNADIENEDIOLS; SCLERA; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 84869471879     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2012.0063     Document Type: Article

References (25)

1. Cunningham, M.A., Edelman, J.L., and Kaushal, S. Intravitreal steroids for macular edema: the past, the present, and the future. Surv. Ophthalmol. 53:139-149, 2008. (Pubitemid 351391933)
2. Kabat, A.G. Uveitis. In: Bartlett, J.D., and Jaanus, S.D., eds. Clinical Ocular Pharmacology, 5th edn. St Louis: Butterworth Heinemann; 2008; p. 587-599.
3. Dickerson Jr., J.E., Dotzel, E., and Clark, A.F. Steroidinduced cataract: new perspectives from in vitro and lens culture studies. Exp. Eye Res. 65:507-516, 1997. (Pubitemid 27454951)
4. Galor, A., Jabs, D.A., Leder, H.A., Kedhar, S.R., Dunn, J.P., et al. Comparison of antimetabolite drugs as corticosteroidsparing therapy for noninfectious ocular inflammation. Ophthalmology. 115:1826-1832, 2008.
5. Soheilian, M., Karimi, S., Ramezani, A., and Peyman, G.A. Pilot study of intravitreal injection of diclofenac for treatment of macular edema of various etiologies. Retina. 30:509- 515, 2010.
6. Kim, S.J., Flach, A.J., Jampol LM. Nonsteroidal antiinflammatory drugs in ophthalmology. Surv. Ophthalmol. 55:108-133, 2010.
7. Iturralde, D., Spaide, R.F., Meyerle, C.B., Klancnik, J.M., Yannuzzi, L.A., et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina. 26:279-284, 2006. (Pubitemid 44318180)
8. Mason 3rd, J.O., Albert Jr., M.A., and Vail, R. Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema. Retina. 26:356-357, 2006. (Pubitemid 44318197)
9. Malone, P.E., Herndon, L.W., Muir, K.W., and Jaffe, G.J. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma. Am. J. Ophthalmol. 149:800-806, 2010.
10. Gerometta, R., Spiga, M.G., Borrá s, T., and Candia, O.A. Treatment of sheep steroid-induced ocular hypertension with a glucocorticoid-inducible MMP1 gene therapy virus. Invest. Ophthalmol. Vis. Sci. 51:3042-3048, 2010.
11. Clark, A.F. Mechanism of action of the angiostatic cortisene anecortave acetate. Surv. Ophthalmol. 52:S26-S34, 2007. (Pubitemid 46111002)
12. Penn, J.S., Rajaratnam, V.S., Collier, R.J., and Clark, A.F. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 42:283-290, 2001. (Pubitemid 32059442)
13. DeFaller, J.M., and Clark, A.F. A new pharmacological treatment for angiogenesis. In: Taylor, H.R., ed. Pterygium. The Hague, The Netherlands: Kugler Publications; 2000; p. 159-181.
14. Robin, A.L., Suan, E.P., Sjaarda, R.N., Callanan, D.G., and DeFaller, J. Reduction of intraocular pressure with anecortave acetate in eyes with ocular steroid injection-related glaucoma. Arch. Ophthalmol. 127:173-178, 2009.
15. Candia, O.A., Gerometta, R., Millar, J.C., and Podos, S.M. Supression of corticosteroid-induced ocular hypertension in sheep by anecortave. Arch. Ophthalmol. 128:338-343, 2010.
16. Robin, A.L., Clark, A.F., Covert, D.W., Krueger, S., Bergamini, M.V.W., et al. Anterior juxtascleral delivery of anecortave acetate in eyes with primary open-angle glaucoma: a pilot investigation. Am. J. Ophthalmol. 2009; 147:45-50.
17. Jonas, J.B., Degenring, R.F., Kreissig, I., Akkoyun, I., and Kamppeter, B.A. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology. 112:593-598, 2005. (Pubitemid 41108858)
18. Lau, L.I., Chen, K.C., Lee, F.L., Chen, S.J., Ko, Y.C., et al. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection in a Chinese population. Am. J. Ophthalmol. 146:573-578, 2008.
19. Konstantopoulos, A., Williams, C.P.R., Newsom, R.S., and Luff, A.J. Ocular morbidity associated with intravitreal triamcinolone acetonide. Eye. 21:317-320, 2007. (Pubitemid 46358790)
20. Goldstein, D.A., Godfrey, D.G., Hall, A., Callanan, D.G., Jaffe, G.J., et al. Intraocular pressure in patients with uveitis treated with fluocinolone acetonide implants. Arch. Ophthalmol. 125:1478-1485, 2007. (Pubitemid 350106679)
21. McNatt, L.G., Weimer, L., Yanni, J., and Clark, A.F. Angiostatic activity of steroids in the chick embryo CAM and rabbit cornea models of neovascularization. J. Ocul. Pharmacol. Ther. 15:413-423, 1999. (Pubitemid 29480958)
22. Netland, P.A., Landry, T., Sullivan, E.K., Andrew, R., Silver, L., et al. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am. J. Ophthalmol. 132:472-484, 2001. (Pubitemid 32904567)
23. Becker, B., and Hahn, K.A. Topical corticosteroids and heredity in primary open-angle glaucoma. Am. J. Ophthalmol. 57:543-551, 1964.
24. Armaly, M.F. The heritable nature of dexamethasoneinduced ocular hypertension. Arch. Ophthalmol. 75:32-35, 1966.
25. Armaly, M.F. Inheritance of dexamethasone hypertension and glaucoma. Arch. Ophthalmol. 77:747-751, 1967.